Cargando…
Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586163/ https://www.ncbi.nlm.nih.gov/pubmed/36276227 http://dx.doi.org/10.2147/VHRM.S390936 |
_version_ | 1784813637446139904 |
---|---|
author | Güven, Alper Tuna Özdede, Murat |
author_facet | Güven, Alper Tuna Özdede, Murat |
author_sort | Güven, Alper Tuna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9586163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-95861632022-10-22 Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] Güven, Alper Tuna Özdede, Murat Vasc Health Risk Manag Letter Dove 2022-10-17 /pmc/articles/PMC9586163/ /pubmed/36276227 http://dx.doi.org/10.2147/VHRM.S390936 Text en © 2022 Güven and Özdede. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Güven, Alper Tuna Özdede, Murat Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title | Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title_full | Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title_fullStr | Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title_full_unstemmed | Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title_short | Commentary and Critique to “VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines” by Abukhalil et al [Letter] |
title_sort | commentary and critique to “vte prophylaxis therapy: clinical practice vs clinical guidelines” by abukhalil et al [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586163/ https://www.ncbi.nlm.nih.gov/pubmed/36276227 http://dx.doi.org/10.2147/VHRM.S390936 |
work_keys_str_mv | AT guvenalpertuna commentaryandcritiquetovteprophylaxistherapyclinicalpracticevsclinicalguidelinesbyabukhaliletalletter AT ozdedemurat commentaryandcritiquetovteprophylaxistherapyclinicalpracticevsclinicalguidelinesbyabukhaliletalletter |